chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a nurse practitioner concerning a 15 week old patient who on 02-NOV-2007 was vaccinated with the first dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human-bovine).  On 30-NOV-2007 the patient experienced inconsolable crying and was seen by the reporting nurse practitioner and sent to the ER with a suspected possible intussusception and subsequently hospitalized.  Ultrasound studies and additional tests were performed.  Diagnosis was unknown at this time.  It was unknown if the patient was still hospitalized.  The outcome was unknown.  Additional information has been requested.  1/11/08 Received vax records from provider  which confirms RO dose & lot as 0942U, #1.  Additional vax info added for Prevnar, Pediarix & ActHib.  1/18/08 Reviewed hospital ER medical records of 11/30/07 which reveal patient experienced irritability, difficulty sleeping, & low grade fever.  Seen in clinic & referred to ER to r/o IS.   D/C to home from ER w/o final dx. FINAL DX: none provided other than fussiness.
Severe vertigo, nausea and vomiting lasting 7 plus hours 2 times, one of which i went to the ER for which was on 2-12-21, the other episode was in January after the vaccine, unsure of date.  The ER administered Vistaril which helped alleviate the symptoms.  I now have daily vertigo, occasional nausea, occasional palpitations and have had multiple testing with no actual results.  They have diagnosed me with Menieres Disease and i am now taking hydrochlorothiazide, and betahistine, and PRN meclizine.
pt recvd 3 doses of Engerix-B & titer report dated 27NOV91 indicated pt did not respond;
COVID Vaccine Breakthrough Case  Pfizer Dose 1 4/13/21 (Er8732) Pfizer Dose 2 5/5/21 (ER8736) COVID Positive 12/6/21  12/6/21: Patient is a 73-year-old female with a 3 day history of abdominal pain.  She did not seek treatment initially because she felt it may be related to a previous history of diverticulitis.  She subsequently was seen by her PCP as an outpatient and CT scan and labs were ordered. What appears to be perforated small intestine with contrast extravasation was seen on CT and she was brought by her husband to a HCF for surgical evaluation.  she complains mostly of diffuse abdominal pain at this point. She has also had retching.  She last had approximately 1 cup of Sherbert p.o. at 11:00  12/14/21: Patient presented to the emergency department with a 3 day history of abdominal pain. She underwent an outpatient CT scan abd/pelvis which was concerning for perforation of the small intestine with contrast extravasation. She underwent the above the procedure, recovered in the CU and was admitted to the Surgical specialty unit for postoperative recovery.  Patient was tested for COVID-19 and the emergency department which was positive.  She was put on COVID precautions.  Hospitalist team was consulted.  A Foley catheter was left in place for accurate I&O.  An NG tube was left in place for gastric decompression.  She was given oxygen per nasal cannula to keep oxygen levels above 92%.  She was kept NPO with ice chips.  As her bowel function returned her NG tube was removed.  She was started on clear liquids and advance as tolerated.  She worked with PT and OT for strengthening conditioning.  She worked with her incentive spirometer for pulmonary toilet.   Her oxygen was weaned to room air as tolerated.   she met discharge criteria.  Her incision remained clean dry well approximated no surrounding erythema or induration.
Facial swelling on 10/14/17. She took BENADRYL and swelling resolved. On 10/23/17, she was placed on Observation Unit with periorbital edema and redness. She was diagnosed with periorbital cellulitis. She was treated with steroids, Clindamycin and PEPCID.
Client developed nausea, hot flashes with subsequent chills, and dizziness.  Blood pressure dropped.  No loss of consciousness.
right thigh induration and discoloration; macular, papular rash on the torso, face, extremities, palms, and soles of feet; the patient had fever of 101.2 F; right thigh induration; Koplik's spots in the mouth; left ear infection; This spontaneous report as received from a nurse refers to a 12 month old female patient. The concomitant medications included hepatitis a virus vaccine inactivated (HAVRIX) and pneumococcal 13v conj vaccine (crm197) (PREVNAR 13). None pertinent medical history, drug reactions and allergies were provided.  On 10-JAN-2020, the patient was vaccinated with dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) recombinant human albumin (rHA), subcutaneously, lot # S013711, expiration date 11-JAN-2020 (exact dose not reported) for prophylaxis. Other suspect therapies included sterile diluent (STERILE DILUENT) (dose, route of administration, indication, lot# and expiration date were not reported). On 11-JAN-2020, the patient had fever of 38.44 degrees of Celsius (101.2 degrees F), right thigh induration and discoloration, Koplik's spots in the mouth, macular, papular rash on the torso, face, extremities, palms, and soles of feet. It was reported that the treatment was given for adverse event. On 22-JAN-2020, the patient was prescribed diphenhydramine hydrochloride (BENADRYL) and cefdinir for left ear infection. Lot Check requested, reporter requested response as quickly as possible. The flu test was performed on an unknown date and the result was negative. It was reported that the patient sought medical attention and the intervention to prevent serious criteria was needed. The nurse also reported that there was no cancer nor overdose event. The nurse informed that the cases were likely mild case of measles and would most likely not result in any samples being submitted to the Varicella Zoster Virus Identification Program (VZVIP). The outcome of pyrexia was reported as recovered/resolved on 23-JAN-2020. The outcome of right thigh induration and discoloration, Koplik's spots in the mouth, macular, papular rash on the torso, face, extremities, palms, and soles of feet was unknown.  The causality assessment between the events and the suspect therapies was not provided.  Upon internal review, the events of fever, right thigh induration and discoloration, Koplik's spots in the mouth, macular, papular rash on the torso, face, extremities, palms, and soles of feet was determined to be medically significant.  This is one of five cases received from the same reporter.; Sender's Comments:  US-009507513-2002USA001548: US-009507513-2002USA001496: US-009507513-2002USA001425: US-009507513-2002USA001134:
5 yr old dx. with asthma was given H1N1 Flumist. Pt. complained next day of "rattle" in his throat. Mother used humidifier in his bedroom with improvement. No medication or doctor visit needed.
Headache, nausea, chills, sore arm.  Later in the day had joint/bone pain in opposite arm (left shoulder).  Nausea and headache were milder the next day
Lump (size of chickpea) noticed/felt in upper left arm near base of armpit. Left arm occasionally feels slightly numb (fallen "asleep" sensation). 4/25/2021 at 10AM. No treatment sought yet, noticed at home.
Information has been received from a consumer concerning her 20 year old daughter with a history of warts on her hands (approximately August 2006), who in February or march 2007, was vaccinated with a first dose of Gardasil, intramuscularly. Approximately two weeks after this dose, the patient developed genital warts. Subsequently, the patient received her second dose of Gardasil, intramuscularly (date not reported). Subsequently, the patient developed a bladder infection. The patient sought unspecified medical attention. The patient's genital warts and bladder infection persisted. No further information is available.
Patient received Hepatitis A vaccine at 8 wks of age. No adverse reaction noted. Follow-up visit occurred 1-29-2015.
Report 20010268091 describes a 53 year old female who did not respond to the hep B vaccine (Engerix-B) immunization series. Medical history, concurrent conditions, and concurrent medications were not specified. On 03/21/2001, 04/30/2001, and 09/24/2001, the vaccinee received her first, second, and third intramuscular injections of Engerix-B, respectively. A titer (NOS) drawn for this vaccinee on 11/02/2001, 39 days after the 3rd injection of Engerix-B was "negative."
Bad headaches; Extreme fatigue; Hot flashes; Vertigo; Weakness; Left hand to left elbow tingling; Left hand to left elbow tingling with pain; Left hand to left elbow tingling with pain; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3184) via an unspecified route of administration in the left arm on 08Sep2021 at 14:30 (at the age of 72-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included atenolol (MANUFACTURER UNKNOWN), amitriptyline (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and alendronate sodium (ALENDRONAT) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Sep2021 at 09:00 the patient experienced bad headaches, extreme fatigue, hot flashes, vertigo, weakness, left hand to left elbow tingling, left elbow pain and left-hand pain. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events bad headaches, extreme fatigue, hot flashes, vertigo, weakness, left hand to left elbow tingling, left elbow pain and left hand pain were not recovered at the time of this report.
On 8/15/09 about 6:00pm child developed fever  and was taken to ER where parents were told his fever was 104.5 degrees fahrenheit. Child was tested for pnuemonia, ear infection, and strep throat. ER physician told parents the etiology of child's fever unknown.As of 8/17/09 child continues to run fever parents are alternating giving tylenol and Ibuprofen. Mother doesn't know what the fever was today. Mother to take child to his private physician and notify RN of diagnosis.
Supraclavicular lymphadenopathy. Pain and swelling in the area just above the right collarbone. Taking Tylenol.
Had vaccine on 1/7. Symptoms began on 1/15. Went to the ER on 1/16.   Symptoms started on 1/15 on the right arm, between the elbow joint and the top of the arm ~ 4 inches below the infection site.  Started with some itchiness, got red, presented initially with two hives (one large, one small, was red and irritated), then spread and became one large red 'blob'. A bit warm. (used cortisone topical and took Benadryl).  ER doc noted that it did not present like cellulitis, though it could progress to this. MD did not know what it was, thought it was an allergic reaction to something.
Pain to injection site x 1 week. Unable to reach for phone or put on clothes without pain to injection site treated with ROBAXIN.
Fever, redness and swelling Left thigh seen by medical doctor. Give Tylenol/Motrin for fever and discomfort.
pt had fever, severe irritability & did not walk for 3 days; 5 days post vax devel diarrhea-resolved w/o problems;
1/15/21 severe sore lt deltoid x 3 days.  PM of 1/15, nausea and fatigue.  AM 1/16 awoke with severe chills and nausea. Thru 1/16 & 1/17 severe fatigue, dizziness, GI sx, w/ severe diarrhea. No fever, but chills and hot flashes persisted. I kept falling asleep. My typical activity was severely affected.  Family had to care for me. I am a registered nurse, which helped prevent an ER visit. Benadryl and Advil were minimal help. These symptoms were not mild. Moderate to severe
Patient was admitted for possible CVA, presented with right facial droop. MRI unable to be completed due to pacemaker. Pt was treated and transferred to inpatient rehab
Client received HPV, HAv, MCV4.  Advised to stay seated.  Stated she wanted to go to lobby and went.Family started to walk to WIC clinic.  Started feeling light headed and slid down the wall.  Did not hit head or hurt herself in any way.
Patient was given KINRIX (DTaP + IPV) by mistake he was not due for KINRIX until 04-14-17. Doctor contacted patient. He has no symptoms was doing well.
Sore arm in the injection site, similar to second dose reaction. Have developed swollen lymph nodes in my left armpit with irritation and pain. Did not seek treatment after researching the effects. After 24 hours of onset, the pain started to decrease. 48-60 hours after onset, the pain is nearly gone and swelling has started to decrease. I will be seeing my doctor tomorrow for another reason and will discuss the situation with him. I wanted to report the event even though it has not fully dissipated.
The night of the shots at dinnertime the symptoms began - nose twitching, lots of blinking, eyes rolling back, shoulder going up on left side, chin tucking into collar bone, tired. The doctor said it was a tic disorder. He ordered a CAT scan which was negative & we were referred to a neurologist whom we will see on November 7, 2011.
Narrative: 74 year old female admitted on June 6 2022 with after testing positive in long-term care. She was noted to have fever and hypoxia on transfer to acute care unit for isolation.. He had received Moderna vaccine x 3 on December 28 2020, January 26 2021, and October 29 2021. She was treated with remdesivir 200 mg IV x 1 then 100 mg daily x 4 days, dexamethasone 6 mg IV x 5 days then dexamethasone 6 mg orally x 5 days.. She remained in the acute care unit until June 17 2022 while quarantining and was transferred back to long term care.
This spontaneous report as received from a physician refers to a 65 years old female patient with back issues; the patient is sensitive to many medications and normally takes pediatric medications. The patient was vaccinated with a dose of ZOSTAVAX (Lot number, dose and route not reported) on 27-MAY-2012. No other co-suspects were reported. Concomitant therapy included ADVIL. On 30-MAY-2012, a few days after the vaccination was given, the patient experienced a deep ache in her left leg down to her foot. The patient explained that the pain was now in the joints of her toes (approximately on 30-MAY-2012). No Lab Diagnostics were performed. No treatment was given for the events. At the time of the report, the events had not improved. The patient sought unspecified medical attention. The relatedness for deep ache in her left leg down to her foot and pain in the joints of her toes was unknown for ZOSTAVAX. Additional information is not expected.
Raised red rash on both lower legs, some on the front of the legs ... mostly on the back of the legs
Mother states on 8/20/19 with last vaccine, localized redness and warmth noted on Right arm around injection sight. Worse day of vaccine and got better over next 2 days. No medical attention was required or received.
flu-like sx aching, nausea, h/a for 3 days; fever 102 for 1 day; seen by MD on 29JAN93; shot of PCN & oral ATB given; strange taste in mouth?
Information has been received from a physician concerning a 12 month old white female, with no medical history and no allergies, who on 19Jul05, at approx 1:30pm, was vaccinated with a first dose in the left thigh of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot 649515/0937P). There was no concomitant medication. There was no illness at the time of vaccination and no adverse events following prior vaccination. On 20Jul05 the pt developed an erythematous, maculopapular rash. The reporter indicated that it was on her stomach, chest, extremities, and back. She was afebrile. The child was reported to be generally healthy. The recommended treatment was diphenhydramine hydrochloride (Benadryl). There was no product quality complaint involved. Medical attention was not sought. Follow up information from a physician indicated that in the afternoon of 20Jul05 the pt experienced a rash described as fine, erythematous, and maculopapular on her chest, stomach, and extremities, with less on her back. There were none on her face and none in her genitourinary area. It was reported that the rash resolved in 3-7 days after onset, on approx 25Jul05. Additional information is not expected.
Patient got sick for 2 days; Felt very tired; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Patient got sick for 2 days), FATIGUE (Felt very tired) and CHILLS (Chills) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 037K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jan-2021, the patient experienced ILLNESS (Patient got sick for 2 days), FATIGUE (Felt very tired) and CHILLS (Chills). At the time of the report, ILLNESS (Patient got sick for 2 days) had resolved and FATIGUE (Felt very tired) and CHILLS (Chills) outcome was unknown.            No concomitant medication details were provided.  No treatment medication details were provided.   This case was linked to MOD-2022-440621, MOD-2022-440667 (Patient Link).
It started on 14th of April, and it started at the top of my head a big rash. It was itching very bad. Then I was getting a rash on the top of my forehead and moving down my face on the left side. Then I went to a dermatologist to see if it was shingles, and it was not shingles. On the 17th of April I went to the clinic and they gave me a prescription and I did talk to them about getting the booster, but they told me to keep taking the medication. On the 20th I went to the eye doctor, and he said it was not shingles. I finished the Valtrex, and it went away. On May 3 a week later, it started inching again in my head. They can't see anything no redness nothing and they gave me some shampoo and then it went away no itching at all. Then I started to have issues with my teeth, and they took a X-ray, and they see nothing wrong with my teeth. All of this happen on the left side where I got the shot at.  Right now, I am doing good no problems at all.
Fever; Chills; Body pains; Runny nose; Congestion; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old male patient received BNT162b2 (BNT162B2), on 02Dec2021 as dose 3 (booster), single (Lot number: FH8030) at the age of 44 years intramuscular, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1 SINGLE; Lot number: EN6203), administration date: 24Feb2021, when the patient was 43-year-old, for Covid-19 Immunisation; BNT162b2 (DOSE 2 SINGLE; Lot number: EP7534), administration date: 17Mar2021, when the patient was 43-year-old, for Covid-19 Immunisation. The following information was reported: PAIN (non-serious) with onset 30Jun2022, outcome "not recovered", described as "Body pains"; CHILLS (non-serious) with onset 30Jun2022, outcome "not recovered"; NASAL CONGESTION (non-serious) with onset 30Jun2022, outcome "not recovered", described as "Congestion"; PYREXIA (non-serious) with onset 30Jun2022, outcome "not recovered", described as "Fever"; RHINORRHOEA (non-serious) with onset 30Jun2022, outcome "not recovered", described as "Runny nose". Therapeutic measures were not taken as a result of pyrexia, chills, pain, rhinorrhoea, nasal congestion.  Additional information: The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.
Pt fainted after vaccination, was found lying on floor, supine rigid w/tonic-clonic movements, eyes closed approx 15 sec. postictal confusion. Pt has history of fainting with sight of blood.
Moles were gone/ COVID 19 vaccine helped eliminate the moles; This is a spontaneous report from a contactable consumer (patient) and physician (dermatologist). A 81-year-old male patient received first dose of bnt162b2 (BNT162B2, solution for injection, Lot number was not reported) dose 1 via an unspecified route of administration on Jan2021 (at the age of 81 years old) as dose 1, single and dose 2 via an unspecified route of administration on 15Feb2021, lot number was not reported as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medication was not reported. On an unspecified date of 2021 the patient experienced moles were gone/ covid 19 vaccine helped eliminate the moles. The clinical outcome of the event was recovered on an unspecified date of 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in an unspecified number of adult patients who received SHINGRIX for prophylaxis.  On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain, myalgia, headache and fatigue. On an unknown date, the outcome of the injection site pain, myalgia, headache and fatigue were unknown. It was unknown if the reporter considered the injection site pain, myalgia, headache and fatigue to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not provided. The age group was not reported but it was selected as adult as per vaccine indication. The pharmacist stated that pain at the injection site, fatigue, myalgia and headache was reported by everyone who had gotten the SHINGRIX.
Received 2nd Pfizer Covid vaccine on 1/26/21 experienced extreme headaches, nausea, chills, red rash itching on vaccine area which I still have today 2/2/21.
past medical history of Parkinson's disease, hypertension, BPH, who presents from home after having down 3 times over the past 72 hours. The following problems were addressed: Acute hypoxic respiratory failure secondary to COVID-19 pneumonia.  Patient has been vaccinated previously.  On dexamethasoneto complete 10 days,has completed 5 days of Remdesivir.Currently satting well on room air. Frequent falls, suspect related to above. Continue PT/OTAdmit for COVID pneumonia. Vaccinated completely "3 months ago". Steroids, remdesivir, O2, zinc. discharged today to skilled nursing unit.